BeStock  
Stocks › COLL

Collegium Pharmaceutical COLL

US equityMarket cap rank #3524
$21.97 +$0.04 (+0.18%)
Market open · Oct 8, 10:00 am ET · After hours $21.93 0.00%
Open$22.03
Prev close$21.93
Day range$21.80 – $22.03
Volume32.5K
Market cap$681.05M
P/E (TTM)17.3
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$199.88M+6.3% YoY
Operating profit$3.70M-89.4% YoY
Net profit-$15.05M-225.6% YoY
Diluted EPS-$0.46-235.3% YoY
Free cash flow$70.83M-2.1% YoY
Operating cash flow$71.32M

Revenue, last 8 quarters

$159.3MSep '24$181.9MDec '24$177.8MMar '25$188.0MJun '25$209.4MSep '25$205.4MDec '25$193.5MMar '26$199.9MJun '26

Net profit, last 8 quarters

$9.3MSep '24$12.5MDec '24$2.4MMar '25$12.0MJun '25$31.5MSep '25$17.0MDec '25$14.5MMar '26$-15.1MJun '26

Diluted EPS by quarter

0.27Sep '240.36Dec '240.07Mar '250.34Jun '250.84Sep '250.46Dec '250.40Mar '26-0.46Jun '26

Free cash flow by quarter

$-9.2MSep '24$84.1MDec '24$54.6MMar '25$72.4MJun '25$78.3MSep '25$122.4MDec '25$56.8MMar '26$70.8MJun '26

Annual revenue

$310.0MFY20$276.9MFY21$463.9MFY22$566.8MFY23$631.4MFY24$780.6MFY25

Profitability & balance sheet

Gross margin60.0%
Operating margin19.5%
Net margin5.9%
Return on equity17.6%
Return on assets2.6%
Return on invested capital7.1%
Current ratio1.03
Liabilities / assets85.4%
Cash & investments$129.47M
Total debt$1.09B
Net cash (debt)-$965.50M
Free cash flow / sales40.6%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • BELBUCA$57.67M 28.9%
  • Jornay PM$46.06M 23.0%
  • Xtampza Extended-release (ER)$45.01M 22.5%
  • Nucynta Extended-release (ER)$15.72M 7.9%
  • Nucynta Immediate-release (IR)$14.36M 7.2%
  • Azstarys$12.91M 6.5%
  • Symproic$3.02M 1.5%
  • Nucynta Extended-release (ER) Authorized Generic (AG)$2.78M 1.4%
  • Nucynta Immediate-release (IR) Authorized Generic (AG)$2.36M 1.2%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $199.88M $193.52M $780.57M $205.45M $209.36M
Total Operating Revenue $199.88M $193.52M $780.57M $205.45M $209.36M
Cost of Revenue $89.59M $76.27M $317.31M $77.07M $80.19M
Gross Profit $110.29M $117.25M $463.26M $128.38M $129.17M
Operating Expense $106.59M $86.35M $284.80M $67.64M $67.10M
Selling and Admin Expenses $106.59M $86.35M $284.80M $67.64M $67.10M
Operating Profit $3.70M $30.90M $178.45M $60.74M $62.07M
Net Non-Operating Interest Income (Expense) -$17.23M -$12.16M -$71.02M -$15.73M -$18.65M
Non-Operating Interest Income $2.29M $3.71M $11.29M $3.57M $3.12M
Non-Operating Interest Expense $19.52M $15.86M $82.31M $19.29M $21.77M
Special Income (Charges) $0.00 $0.00 -$14.81M -$15.98M $19,000.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 -$1.18M -$19,000.00 -$19,000.00
Pretax Profit -$13.53M $18.74M $92.62M $29.04M $43.44M
Tax $1.52M $4.24M $29.75M $12.07M $11.93M
Net Profit -$15.05M $14.50M $62.87M $16.96M $31.51M
Profit from Continuing Operations -$15.05M $14.50M $62.87M $16.96M $31.51M
Net Income to Parent Company -$15.05M $14.50M $62.87M $16.96M $31.51M
Net Income to Common Stockholders -$15.05M $14.50M $62.87M $16.96M $31.51M
Basic EPS -$0.46 $0.45 $1.98 $0.54 $1.00
Diluted EPS -$0.46 $0.40 $1.73 $0.46 $0.84
Other Income (Expense) – – -$14.81M -$15.98M $19,000.00
-Less:Other Special Charges – – $15.99M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $2.14B $1.65B $1.66B $1.66B $1.61B
Total Current Assets $608.01M $745.67M $691.41M $691.41M $613.87M
Cash and Cash Equivalents & Short-Term Investments $129.47M $421.75M $386.68M $386.68M $285.86M
-Cash and Cash Equivalents $129.47M $268.65M $231.25M $231.25M $150.10M
-Short Term Investments $0.00 $153.11M $155.43M $155.43M $135.77M
Receivables $285.10M $228.76M $211.33M $211.33M $233.95M
-Accounts Receivable $285.10M $228.76M $211.33M $211.33M $233.95M
Prepaid Assets $60.33M $32.56M $29.40M $29.40M $36.16M
Inventory $113.27M $42.74M $40.91M $40.91M $38.05M
Restricted Cash $19.85M $19.85M $19.85M $19.85M $19.85M
Total Non-Current Assets $1.53B $906.29M $965.42M $965.42M $993.46M
Net PPE $14.44M $15.64M $16.20M $16.20M $16.68M
-Gross PPE $14.44M $15.64M $32.74M $32.74M $16.68M
Goodwill and Other Intangible Assets $1.38B $759.96M $815.44M $815.44M $870.91M
-Goodwill $190.18M $145.93M $145.93M $145.93M $145.93M
-Other Intangible Assets $1.19B $614.04M $669.51M $669.51M $724.98M
Non-Current Deferred Assets $120.77M $113.57M $112.54M $112.54M $102.48M
Other Non-Current Assets $16.30M $17.12M $21.25M $21.25M $3.39M
Total Liabilities $1.82B $1.34B $1.36B $1.36B $1.33B
Total Current Liabilities $589.86M $434.97M $440.03M $440.03M $452.93M
Payables $50.06M $41.00M $39.25M $39.25M $32.04M
-Accounts Payable $9.24M $6.83M $10.66M $10.66M $7.65M
-Total Tax Payable $11.10M $16.61M $11.03M $11.03M $6.83M
-Other Payable $29.72M $17.57M $17.57M $17.57M $17.57M
Current Accrued Expenses $460.48M $352.91M $363.55M $363.55M $348.20M
Short-Term Debt and Capital Lease Obligation $56.56M $34.07M $30.41M $30.41M $65.96M
-Current Debt $55.00M $32.63M $29.00M $29.00M $64.58M
-Current Capital Lease Obligation $1.56M $1.45M $1.41M $1.41M $1.37M
Current Deferred Liabilities $667,000.00 $667,000.00 $667,000.00 $667,000.00 $667,000.00
Other Current Liabilities $18.00M $2.44M $2.44M $2.44M $2.45M
Total Non-Current Liabilities $1.23B $904.56M $915.13M $915.13M $879.59M
Long Term Debt and Capital Lease Obligation $1.04B $773.98M $784.46M $784.46M $748.03M
-Long Term Debt $1.04B $770.20M $780.33M $780.33M $743.53M
-Long Term Capital Lease Obligation $3.41M $3.79M $4.13M $4.13M $4.50M
Non-Current Deferred Liabilities $171.10M $130.58M $130.67M $130.67M $131.56M
Other Non-Current Liabilities $22.96M – – – –
Total Equity $311.91M $312.42M $301.68M $301.68M $274.81M
Stockholders' Equity $311.91M $312.42M $301.68M $301.68M $274.81M
Capital Stock $41,000.00 $41,000.00 $41,000.00 $41,000.00 $41,000.00
-Common Stock $41,000.00 $41,000.00 $41,000.00 $41,000.00 $41,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $636.06M $621.74M $624.95M $624.95M $615.08M
Retained Earnings -$101.68M -$86.63M -$101.13M -$101.13M -$118.09M
Less: Treasury Stock $222.51M $222.51M $222.51M $222.51M $222.51M
Gains/Losses Not Affecting Retained Earnings $0.00 -$219,000.00 $319,000.00 $319,000.00 $292,000.00
Other Current Assets – – $3.24M $3.24M –
-Accumulated Depreciation – – -$16.54M -$16.54M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $71.32M $57.11M $329.32M $123.05M $78.44M
Net cash flow from continuing operations $71.32M $57.11M $329.32M $123.05M $78.44M
Net Income from Continuing Operations -$15.05M $14.50M $62.87M $16.96M $31.51M
Depreciation & Depletion & Amortization $64.77M $55.94M $226.07M $56.40M $56.51M
Deferred Tax -$7.16M -$968,000.00 -$25.66M -$10.07M -$12.13M
Other Non-Cash Items $721,000.00 $799,000.00 $5.45M $437,000.00 $1.48M
Change in Working Capital $13.60M -$23.85M $3.76M $33.83M -$8.50M
-Change in Receivables $2.13M -$17.43M $17.20M $22.62M -$20.93M
-Change in Inventory -$597,000.00 -$1.83M -$5.35M -$2.86M $96,000.00
-Change in Prepaid Assets -$8.23M $4.13M -$7.97M -$8.19M $21.34M
-Change in Payables and Accrued Expense $20.47M -$8.55M $74,000.00 $22.41M -$8.97M
-Change In Other Working Capital -$166,000.00 -$167,000.00 -$197,000.00 -$152,000.00 –
Net cash flow from investing -$502.59M $1.63M -$63.53M -$20.07M -$30.87M
Net Cash Flow from Continuing Investing Activities -$502.59M $1.63M -$63.53M -$20.07M -$30.87M
Net PPE Purchase and Sale -$496,000.00 -$270,000.00 -$1.74M -$689,000.00 -$188,000.00
Net Investment Purchase and Sale $153.31M $1.90M -$61.79M -$19.38M -$30.68M
Financing Cash Flow $292.09M -$21.34M -$110.25M -$21.82M -$14.82M
Net Cash Flow from Continuing Financing Activities $292.09M -$21.34M -$110.25M -$21.82M -$14.82M
Net Issuance Payments Of Debt $292.25M -$7.25M -$70.38M -$21.95M -$16.15M
Proceeds from Stock Option Exercised $481,000.00 $1.34M $5.64M $985,000.00 $2.29M
Net Other Financing Charges -$646,000.00 -$15.43M -$20.40M -$861,000.00 -$964,000.00
Ending Cash Balance $150.38M $289.56M $252.16M $252.16M $171.00M
Net Change in Cash -$139.18M $37.40M $155.55M $81.16M $32.75M
Beginning Cash Balance $289.56M $252.16M $96.61M $171.00M $138.25M
Free Cash Flow $70.83M $56.84M $327.58M $122.36M $78.25M
Gain/Loss from Continuing Operations – – $15.99M – –
Net Business Purchase and Sale – – $0.00 $0.00 $0.00
Net Common Stock Issuance – – -$25.10M $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on COLL.

Leave a comment

Scroll to Top